Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Efficacy of Artemisia Pollen AIT in Seasonal Allergic Rhinitis
NCT05318157Phase 4Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Mar 2022
- Primary completion
- Oct 2024
- Modality
- Prophylactic Vaccines, Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 4 trial of artemisia annua allergen extract in seasonal allergic rhinitis (SAR), sponsored by Beijing Tongren Hospital. Status: unknown.
02
Drugs
artemisia annua allergen extract
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT05318157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05318157.